COMP <GO>
ARCT vs AVIR // FORWARD P/E MULTIPLE
Arcturus Therapeutics Holdings Inc. (NASDAQ) VS. Atea Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: ARCT 1
— AVIR 2
■ METRIC PARITY
LAST: $12.15 (+0.66%) • MKT CAP: $345.3M
forward-pe
—
LAST: $4.31 (+0.94%) • MKT CAP: $345.7M
forward-pe
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ARCT VS. AVIR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ARCT | AVIR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -21.57% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -46.10% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.25 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 3/9 | -1.00 | AVIR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.2 | 40.9 | +10.30 | ARCT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $345.3M | $345.7M | -$342.0K | AVIR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ARCT REV | AVIR REV | ARCT GROSS % | AVIR GROSS % | ARCT FCF | AVIR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $82.0M | $0 | — | — | -$74.5M | -$132.0M |
| FY 2024 | $152.3M | $0 | — | — | -$60.4M | -$135.5M |
| FY 2023 | $166.8M | $0 | — | — | -$18.1M | -$85.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ARCT // BETA —
AVIR // BETA —